A Co-Reactivation Model of Cytomegalovirus and Epstein-Barr Virus after Allogeneic Hematopoietic Stem Cell Transplantation Was Constructed to Predict Mortality after Transplantation

被引：0
|
作者：
Ren, Jinhua [1 ,2 ,3 ]
Chen, Shaozhen [1 ,2 ]
Hu, Jianda [4 ,5 ,6 ]
Yang, Ting [1 ,2 ,3 ,4 ]
机构：
[1] Fujian Med Univ, Fujian Inst Hematol, Dept Hematol,Union Hosp, Fujian Prov Key Lab Hematol, Fuzhou, Peoples R China
[2] Fujian Med Univ, Affiliated Hosp 1, Dept Hematol, Fuzhou, Peoples R China
[3] Fujian Med Univ, Natl Reg Med Ctr, Affiliated Hosp 1, Dept Hematol, Binhai Campus, Fujian, Peoples R China
[4] Fujian Med Univ, Inst Precis Med, Fuzhou, Peoples R China
[5] Fujian Med Univ, Affiliated Hosp 2, Dept Hematol, Quanzhou, Peoples R China
[6] Fujian Inst Hematol, Union Hosp, Fujian Prov Key Lab Hematol, Fuzhou, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-191078
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Epstein Barr Virus (EBV) Reactivation After Reduced Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem Cell Transplantation.
    Peric, Zinaida
    Cahu, Xavier
    Chevallier, Patrice
    Brissot, Eolia
    Malard, Florent
    Guillaume, Thierry
    Delaunay, Jacques
    Ayari, Sameh
    Dubruille, Viviane
    Le Gouill, Steven
    Mahe, Beatrice
    Gastinne, Thomas
    Blin, Nicolas
    Saulquin, Beatrice
    Harrouseau, Jean-Luc
    Moreau, Philippe
    Milpied, Noel
    Coste-Burel, Marianne
    Imbert-Marcille, Berthe-Marie
    Mohty, Mohamad
    BLOOD, 2010, 116 (21) : 539 - 540
  • [42] Epstein–Barr virus reactivation after allogeneic stem cell transplantation without lymph node enlargement
    William H. Krüger
    Frank Schüler
    Christian Lotze
    Günther Schwesinger
    Renate Mentel
    Christoph Busemann
    Gottfried Dölken
    Annals of Hematology, 2005, 84 : 477 - 478
  • [43] Cyclosporine area under the curve after allogeneic hematopoietic stem cell transplantation is an indicator of Epstein-Barr virus DNAemia
    Christopeit, Maximilian
    Janssen, Nils
    Weber, Thomas
    Bacher, Ulrike
    Lautenschlaeger, Christine
    Oehme, Albrecht
    Kekule, Alexander S.
    Schmoll, Hans-Joachim
    LEUKEMIA & LYMPHOMA, 2013, 54 (01) : 133 - 137
  • [44] The Viral Load of Epstein-Barr Virus in Blood of Children after Hematopoietic Stem Cell Transplantation*
    Jun, Wang Wen
    Qiao, Feng Shun
    Feng, He
    Jun, Du Hai
    Miao, Feng
    Fang, Wang Rui
    Yong, Mei Guo
    Mi, Liu
    Rong, Liu
    Lan, Yao Hai
    Jun, Han
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2022, 35 (09) : 804 - 810
  • [45] Rituximab in the Treatment of Epstein-Barr Virus Infection after hematopoietic stem cell Transplantation in Children
    Peng, Zhiyong
    Li, Chunfu
    He, Yuelin
    BLOOD, 2014, 124 (21)
  • [46] The Viral Load of Epstein-Barr Virus in Blood of Children after Hematopoietic Stem Cell Transplantation
    WANG Wen Jun
    FENG Shun Qiao
    HE Feng
    DU Hai Jun
    FENG Miao
    WANG Rui Fang
    MEI Guo Yong
    LIU Mi
    LIU Rong
    YAO Hai Lan
    HAN Jun
    BiomedicalandEnvironmentalSciences, 2022, 35 (09) : 804 - 810
  • [47] Epstein-Barr Virus Related Lymphoproliferations After Stem Cell Transplantation
    Sica, Simona
    Metafuni, Elisabetta
    Bellesi, Silvia
    Chiusolo, Patrizia
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2009, 1 (02)
  • [48] Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
    Li Xuan
    Fen Huang
    Zhiping Fan
    Hongsheng Zhou
    Xian Zhang
    Guopan Yu
    Yu Zhang
    Can Liu
    Jing Sun
    Qifa Liu
    Journal of Hematology & Oncology, 5
  • [49] Weekly Low-Dose Rituximab As the Preemptive Management of Epstein-Barr Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Novel Strategy?
    Chen, Feng
    Depei, Wu
    Tao, Tao
    Gong, Wei
    Ye, Chunmei
    Tang, XiaoWen
    Han, Yue
    Qiu, Huiying
    BLOOD, 2015, 126 (23)
  • [50] Use of rituximab in the treatment of Epstein-Barr virus reactivation after allogeneic stem cell transplantation: a retrospective study in 86 patients
    Auger, S.
    Mines, M. L.
    Fegueux, N.
    Ceballos, P.
    Segondy, M.
    Rossi, J. -F.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S211 - S211
12345